Top Markets
Coin of the day
RetinalGenix Technologies Inc. RetinalGenix Technologies Inc.

RetinalGenix Technologies Inc.

RTGN
Pozycja w akcjach #23316
RetinalGenix Technologies Inc. is a company dedicated to research and... RetinalGenix Technologies Inc. is a company dedicated to research and development within the field of ophthalmology. Its core mission involves devising advanced technologies aimed at detecting, supervising, identifying, and treating a range of visual conditions, including those affecting the eyes and those that could lead to vision loss. Their product lineup features the RetinalGeniX Imaging System, an apparatus for broad-scale retinal imaging and screening that does not require pupil dilation, particularly useful for diabetic patients. Additionally, they offer the RetinalCam, a device designed for real-time retinal monitoring and imaging in a home setting, which includes an alert function for medical practitioners. The company was founded in 2017, with its principal offices located in Petaluma, California. RetinalGenix Technologies Inc. operates as a subsidiary of Sanovas Ophthalmology, LLC.
Cena akcji
$4.00
Ostatnia synchronizacja: 2026-08-20
Kapitalizacja rynkowa
$75.37M
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
12.99%
Kraj
US
Handel RetinalGenix Technologies Inc. (RTGN)

Kategoria

Historia ceny akcji dla RetinalGenix Technologies Inc. (RTGN)
Najwyższa cena zamknięcia: $4.00 dnia 2026-08-01

Najniższa cena zamknięcia: $6.94 dnia 2014-03-01
Historia cen akcji firmy RetinalGenix Technologies Inc. od 2014 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) 9.70%
2025 100.00%
2024 -48.22%
2023 -65.67%
2022 116.03%
2015 10.30%
2014 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$116.64 -12.03%
US
$330.03 -16.28%
US
$93.47 0.81%
IE
$50.38 -52.55%
US
$47.68 -15.22%
DE